PD-L1 Distribution and Perspective for Cancer Immunotherapy—Blockade, Knockdown, or Inhibition

Cancer immunotherapy involves blocking the interactions between the PD-1/PD-L1 immune checkpoints with antibodies. This has shown unprecedented positive outcomes in clinics. Particularly, the PD-L1 antibody therapy has shown the efficiency in blocking membrane PD-L1 and efficacy in treating some adv...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yilun, Chen, Weiyu, Xu, Zhi Ping, Gu, Wenyi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718566/
https://www.ncbi.nlm.nih.gov/pubmed/31507611
http://dx.doi.org/10.3389/fimmu.2019.02022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718566/
https://www.ncbi.nlm.nih.gov/pubmed/31507611
http://dx.doi.org/10.3389/fimmu.2019.02022

Ejemplares similares